The Metal Theory of Alzheimer's Disease

被引:258
|
作者
Bush, Ashley I. [1 ]
机构
[1] Univ Melbourne, Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia
关键词
Alzheimer's disease; amyloid; copper; iron; presenilin; tau; zinc; PLACEBO-CONTROLLED TRIAL; A-BETA; TRANSGENIC MICE; SENILE PLAQUES; DOUBLE-BLIND; IRON-EXPORT; ZINC; COPPER; ACCUMULATION; PBT2;
D O I
10.3233/JAD-2012-129011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain homeostasis of transition metals is severely perturbed in Alzheimer's disease (AD), with extracellular pooling of zinc and copper in amyloid, and intraneuronal accumulation of iron. Rapidly accumulating evidence indicates that these perturbances themselves may contribute significantly to the cognitive loss and neurodegeneration, even in the absence of AD proteopathy. There is now strong evidence that each of the major protein participants in AD pathology has physiologically important interactions with transition metals: A beta PP is the neuronal iron export ferroxidase with a major interaction with ferroportin, presenilins are needed for the import of approximate to 50% of cellular copper and zinc, and tau promotes the export of neuronal iron by facilitating the trafficking of A beta PP to the surface. Therefore, amyloid and tau pathology arise in a milieu of constitutively high metal flux, and the major components of AD pathology may contribute to the disease by failing in their metal transport roles.
引用
收藏
页码:S277 / S281
页数:5
相关论文
共 50 条
  • [31] Alzheimer's disease and Parkinson's disease: archetypal disorders of brain metal homeostasis
    Bush, A. I.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 : S207 - S207
  • [32] Multifunctional metal chelators as potential Alzheimer's disease drugs
    Telpoukhovskaia, Maria A.
    Rodriguez-Rodriguez, Cristina
    Cawthray, Jacqueline F.
    Patrick, Brian O.
    Orvig, Chris
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [33] Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
    Md. Tanvir Kabir
    Md. Sahab Uddin
    Sonia Zaman
    Yesmin Begum
    Ghulam Md Ashraf
    May N. Bin-Jumah
    Simona G. Bungau
    Shaker A. Mousa
    Mohamed M. Abdel-Daim
    Molecular Neurobiology, 2021, 58 : 1 - 20
  • [34] Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease
    Hegde, Muralidhar L.
    Bharathi, P.
    Suram, Anitha
    Venugopal, Chitra
    Jagannathan, Ramya
    Poddar, Pankaj
    Srinivas, Pullabhatla
    Sambamurti, Kumar
    Rao, Kosagisharaf Jagannatha
    Scancar, Janez
    Messori, Luigi
    Zecca, Luigi
    Zatta, Paolo
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (03) : 457 - 468
  • [35] Oxidative processes in Alzheimer's disease:: the role of Aβ-metal interactions
    Lynch, T
    Cherny, RA
    Bush, AI
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 445 - 451
  • [36] Metal Complexation Mechanisms of Polyphenols Associated to Alzheimer's Disease
    Kola, Arian
    Dudek, Dorota
    Valensin, Daniela
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (35) : 7278 - 7294
  • [37] Therapeutic treatments for Alzheimer's disease based on metal bioavailability
    Crouch, Peter J.
    Barnham, Kevin J.
    Bush, Ashley I.
    White, Anthony R.
    DRUG NEWS & PERSPECTIVES, 2006, 19 (08) : 469 - 474
  • [38] Therapeutic Redistribution of Metal Ions To Treat Alzheimer's Disease
    Crouch, Peter J.
    Barnham, Kevin J.
    ACCOUNTS OF CHEMICAL RESEARCH, 2012, 45 (09) : 1604 - 1611
  • [39] Metal-protein attenuating compounds and Alzheimer"s disease
    Ritchie, CW
    Bush, AI
    Masters, CL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (12) : 1585 - 1592
  • [40] Current understanding of metal ions in the pathogenesis of Alzheimer's disease
    Wang, Lu
    Yin, Ya-Ling
    Liu, Xin-Zi
    Shen, Peng
    Zheng, Yan-Ge
    Lan, Xin-Rui
    Lu, Cheng-Biao
    Wang, Jian-Zhi
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)